E Asch|E Podack - JoVE Visualize

Showing results (1-10 of 17) with videos related to

Pageof 2

Sort By:

The Journal of Clinical Investigation|May 1, 1990

Vitronectin binds to activated human platelets and plays a role in platelet aggregationE Asch, E Podack

Blood|July 4, 2001

Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesisZ Jiang, E Podack, R B Levy

Biochemical and Biophysical Research Communications|September 24, 1996

A hammerhead ribozyme that cleaves perforin and fas-ligand RNAs in vitroZ Du, C Ricordi, E Podack, et al.

Journal of Experimental Psychology. General|December 1, 1992

Studies in space orientation. II. Perception of the upright with displaced visual fields and with body tiltedS E Asch, H A Witkin

Scandinavian Journal of Immunology|March 1, 1992

Molecular events in late stages of T-cell functional maturationP J Nelson, R L Geller, E Podack, et al.

The American Journal of Pathology|April 1, 1987

Localization of S protein and its relationship to the membrane attack complex of complement in renal tissueR J Falk, E Podack, A P Dalmasso, et al.

Human Gene Therapy|August 7, 1998

Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymesZ Du, C Ricordi, L Inverardi, et al.

European Journal of Immunology|April 1, 1995

Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathwayS Isaaz, K Baetz, K Olsen, et al.

Blood|January 1, 1991

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in IsraelB S Coller, D A Cheresh, E Asch, et al.

The Journal of Experimental Medicine|July 1, 1990

Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.

Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:

Pageof 2

The Journal of Clinical Investigation|May 1, 1990

Vitronectin binds to activated human platelets and plays a role in platelet aggregationE Asch, E Podack

Blood|July 4, 2001

Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4(+) donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesisZ Jiang, E Podack, R B Levy

Biochemical and Biophysical Research Communications|September 24, 1996

A hammerhead ribozyme that cleaves perforin and fas-ligand RNAs in vitroZ Du, C Ricordi, E Podack, et al.

Journal of Experimental Psychology. General|December 1, 1992

Studies in space orientation. II. Perception of the upright with displaced visual fields and with body tiltedS E Asch, H A Witkin

Scandinavian Journal of Immunology|March 1, 1992

Molecular events in late stages of T-cell functional maturationP J Nelson, R L Geller, E Podack, et al.

The American Journal of Pathology|April 1, 1987

Localization of S protein and its relationship to the membrane attack complex of complement in renal tissueR J Falk, E Podack, A P Dalmasso, et al.

Human Gene Therapy|August 7, 1998

Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymesZ Du, C Ricordi, L Inverardi, et al.

European Journal of Immunology|April 1, 1995

Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathwayS Isaaz, K Baetz, K Olsen, et al.

Blood|January 1, 1991

Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in IsraelB S Coller, D A Cheresh, E Asch, et al.

The Journal of Experimental Medicine|July 1, 1990

Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysisS Meri, B P Morgan, M Wing, et al.

Pageof 2